Загрузка...
Evidence for antibody as a protective correlate for COVID-19 vaccines
A correlate of protection (CoP) is urgently needed to expedite development of additional COVID-19 vaccines to meet unprecedented global demand. To assess whether antibody titers may reasonably predict efficacy and serve as the basis of a CoP, we evaluated the relationship between efficacy and in vit...
Сохранить в:
| Опубликовано в: : | Vaccine |
|---|---|
| Главные авторы: | , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Elsevier Science
2021
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8142841/ https://ncbi.nlm.nih.gov/pubmed/34210573 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2021.05.063 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|